Literature DB >> 6229327

An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.

G M Taylor, W Fergusson, P A Dyer, R Harris, G Morrell.   

Abstract

We describe an acute myelomonocytic leukaemia (E72) devoid of cell-surface HLA-DR antigens, but capable of inducing cellular responses. Leukaemia E72 induced proliferation of normal lymphocytes in primary mixed lymphocyte culture (MLC), which was only weakly inhibited by anti-DR sera. Depletion of a small percentage (congruent to 4%) of DR+ cells on a cell-sorter failed to abrogate the capacity of E72 to stimulate MLC and cell-mediated cytotoxicity (CMC) responses. We found that normal lymphocytes primed with E72 responded in secondary MLC to lymphocytes and leukaemias, suggesting that the lymphocyte-activating determinant (LAD) on E72 is not leukaemia-specific. In addition, E72 induced CMC responses to both leukaemias and lymphocytes. We suggest that E72 may express a novel HLA or non-HLA LAD.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6229327     DOI: 10.1007/bf00199243

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

Review 1.  Ia antigens: definition of the HLA-DRw specificities.

Authors:  J G Bodmer
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

2.  Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.

Authors:  A Zeevi; C Scheffel; K Annen; G Bass; M Marrari; R J Duquesnoy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Characterization of HLA-DR antigens on leukaemic cells.

Authors:  R A Newman; M F Greaves
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

4.  Differentiation linked expression of p28,33 (Ia-like) structures on human leukaemic cells.

Authors:  G Janossy; A H Goldstone; D Capellaro; M F Greaves; J Kulenkampff; M Pippard; K Welsh
Journal:  Br J Haematol       Date:  1977-11       Impact factor: 6.998

5.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

6.  Human MHC class II molecules as differentiation markers.

Authors:  V van Heyningen; K Guy; R Newman; C M Steel
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Allogeneic mixed lymphocyte reactions in humans: pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation.

Authors:  R S Accolla; A Moretta; J C Cerottini
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

8.  Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.

Authors:  G M Taylor; S V Jones; J C Ridway; R Harris
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

9.  Surface Ia-like expression and MLR-stimulating capacity of human leukemic myeloblasts: implications for immunotherapy and prognosis.

Authors:  T D Miale; L A Stenke; J B Lindblom; A M Sjögren; P G Reizenstein; A M Udén; D L Lawson
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

10.  Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.

Authors:  S Shaw; A H Johnson; G M Shearer
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  1 in total

1.  Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

Authors:  L K Ashman; G W Kriek; S J Cooper; D E O'Keefe
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.